206 related articles for article (PubMed ID: 27793046)
1. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.
Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S
Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046
[TBL] [Abstract][Full Text] [Related]
2. Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.
Yao JF; Li XJ; Yan LK; He S; Zheng JB; Wang XR; Zhou PH; Zhang L; Wei GB; Sun XJ
J Biochem Mol Toxicol; 2019 Jun; 33(6):e22316. PubMed ID: 30897285
[TBL] [Abstract][Full Text] [Related]
3. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
[TBL] [Abstract][Full Text] [Related]
4. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
[TBL] [Abstract][Full Text] [Related]
6. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
[TBL] [Abstract][Full Text] [Related]
8. Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.
Sun YL; Liu WD; Ma GY; Gao DW; Jiang YZ; Liu Q; Du JJ
Int J Med Sci; 2013; 10(5):548-59. PubMed ID: 23532910
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.
Seneviratne D; Ma J; Tan X; Kwon YK; Muhammad E; Melhem M; DeFrances MC; Zarnegar R
Gastroenterology; 2015 Jan; 148(1):181-191.e17. PubMed ID: 25244939
[TBL] [Abstract][Full Text] [Related]
10. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway.
Luo Y; Ouyang J; Zhou D; Zhong S; Wen M; Ou W; Yu H; Jia L; Huang Y
Dig Dis Sci; 2018 Apr; 63(4):890-899. PubMed ID: 29427222
[TBL] [Abstract][Full Text] [Related]
12. SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET.
Du F; Li X; Feng W; Qiao C; Chen J; Jiang M; Qiu Z; Qian M; Tian D; Nie Y; Fan D; Wu K; Xia L
Oncogene; 2020 Apr; 39(17):3522-3540. PubMed ID: 32111984
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944
[TBL] [Abstract][Full Text] [Related]
15. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.
Herynk MH; Zhang J; Parikh NU; Gallick GE
J Exp Ther Oncol; 2007; 6(3):205-17. PubMed ID: 17552361
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
[TBL] [Abstract][Full Text] [Related]
17. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
Yu L; Lu Y; Han X; Zhao W; Li J; Mao J; Wang B; Shen J; Fan S; Wang L; Wang M; Li L; Tang J; Song B
Stem Cell Res Ther; 2016 Dec; 7(1):180. PubMed ID: 27906093
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
19. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.
Li W; Xiong X; Abdalla A; Alejo S; Zhu L; Lu F; Sun H
J Biol Chem; 2018 Oct; 293(40):15397-15418. PubMed ID: 30108175
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
